Molecular biomarkers such as CD44, CD133 and ALDH1 have been extensively validated for their prognostic significance for HNSCC cancer stem cells (CSC) [14, 15]
Clinical evidence comes in tiers: mechanistic studies (does the molecule do what it should at the cellular level?), animal studies (does it produce the expected effect in a living organism?), and human trials (does it actually work on the people who will use it?)
Alcoholic Liver Disease (ALD) is the result of the way our body treats alcohol in the liver where alcohol metabolic products lead to the formation of Reactive Oxygen Species (ROS) that harm cells through interacting with fats, proteins, and DNA
PlexusDx helps bridge the gap between genetic insights and clinical decision-making, enabling you and your provider to weigh benefits and risks based on your individual health profile
This suggests that the stability of RBC-NPs can provides long-term protection in vivo